title: Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?
authors.affiliation: Servicio de Medicina Interna, Hospital Son Llatzer, Mallorca, Spain.
authors.forename: Inès
authors.initials: I
authors.lastname: Losada
authors.forename: Leonardo
authors.initials: L
authors.lastname: Sartori
authors.forename: Elena
authors.initials: E
authors.lastname: Di Gianantonio
authors.forename: Margherita
authors.initials: M
authors.lastname: Zen
authors.forename: Maurizio
authors.initials: M
authors.lastname: Clementi
authors.forename: Andrea
authors.initials: A
authors.lastname: Doria
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001842:Bone and Bones / Q000187:drug effects*; D004164:Diphosphonates / Q000009:adverse effects*; D004622:Embryo, Mammalian / Q000187:drug effects*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control; D011247:Pregnancy / Q000187:drug effects*; D012216:Rheumatic Diseases / Q000188:drug therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D004164:Diphosphonates